首页 | 本学科首页   官方微博 | 高级检索  
     

原发性硬化性胆管炎27例临床病理特点分析
引用本文:Zhao XY,Wang WW,Ou XJ,Wang TL,Jia JD. 原发性硬化性胆管炎27例临床病理特点分析[J]. 中华肝脏病杂志, 2010, 18(9): 685-688. DOI: 10.3760/cma.j.issn.1007-3418.2010.09.010
作者姓名:Zhao XY  Wang WW  Ou XJ  Wang TL  Jia JD
作者单位:1. 首都医科大学附属北京友谊医院肝病中心,北京,100050
2. 北京市第六医院
3. 中日友好医院
摘    要:目的 总结原发性硬化性胆管炎(PSC)的临床病理特点,提高临床医师对该病的认识.方法 回顾性分析27例PSC患者的临床资料并随访患者当前情况.临床资料主要包括各项肝功能指标、自身抗体及免疫球蛋白,影像学及病理学检查结果将PSC患者分为大胆管型或小胆管型;治疗措施包括药物、内镜及手术治疗,治疗3~6个月后,ALT≤1.5倍、Tbil≤2倍、ALP≤2.5倍正常上限为有效.大胆管型PSC与小胆管型PSC的疗效比较采用非参数检验CMH法,P<0.05为差异有统计学意义.结果 27例PSC患者中,男性7例,女性20例,平均年龄47.6岁.大胆管型PSC 18例,小胆管型PSC 9例.主要临床表现为黄疸(85.2%)、瘙痒(48.1%)、乏力(68.4%)、腹痛(40.7%)及发热(14.8%);常见体征包括:肝大(44.4%)、脾大(48.1%)、腹水(14.8%)等;胆红素升高10倍以上者占30.8%,IgG异常率81.8%、抗核抗体阳性率69.6%、抗中性粒细胞胞浆抗体阳性率52.9%;合并溃疡性结肠炎者占22.2%,干燥综合征患者占22.2%.经药物、内镜或手术治疗后,部分病例病情缓解,3例死亡;小胆管型PSC的疗效优于大胆管型PSC(66.7%比33.3%,x2=4.173,P=0.041).结论 本组少数PSC患者合并溃疡性结肠炎.小胆管型PSC治疗效果优于大胆管型PSC,提示早期诊治的必要性.

关 键 词:胆管炎,硬化性  结肠炎,溃疡性  熊去氧胆酸  胰胆管造影术,内窥镜逆行

Clinical and pathological features of 27 cases of primary sclerosing cholangitis
Zhao Xin-yan,Wang Wan-wei,Ou Xiao-juan,Wang Tai-ling,Jia Ji-dong. Clinical and pathological features of 27 cases of primary sclerosing cholangitis[J]. Chinese journal of hepatology, 2010, 18(9): 685-688. DOI: 10.3760/cma.j.issn.1007-3418.2010.09.010
Authors:Zhao Xin-yan  Wang Wan-wei  Ou Xiao-juan  Wang Tai-ling  Jia Ji-dong
Affiliation:Liver Research Center Beijing Friendship Hospital, Capital Medical University, Beijing 100050, China.
Abstract:Objective To elucidate clinical and pathological features of primary sclerosing cholangitis (PSC) in order to improve clinician's awareness of this rare disease. Methods We retrospectively analyzed clinical data and follow-up information of 27 PSC patients who were admitted to Beijing Friendship Hospital from January 1990 to November 2009. The patients were classified into classic PSC and small-duct PSC according to biochemistry and imaging results. After 3 to 6 months of therapy, those patients with serum ALT1 ≤ 1.5, TBil ≤ 2 and ALP ≤ 2.5 ULN were determined as good responders. The treatment results between the two groups were compared. Results 9 out of 27 cases of PSC were small duct PSC and 18 cases were large bile duct or classic PSC. Male patients (7) were less than females (20) and the average age was 47.6years. Main clinical symptoms included jaundice (85.2%), pruritis (48. 1%), fatigue (68.4 %), abdominal pain (40.7%) and fever(14.8%), main physical sign included hepatomegaly (44.4%), splenomegaly (48.1%) and ascites (14.8%). Laboratory features included elevated IgG (81.8%), positive ANA (69.6%) and pANCA (52.9%). 22% of these PSC patients had ulcerative colitis or Sjogren's syndrome. A small percentage of patients were responsive to standard therapy, of which small duct PSC had a better response than classic PSC (66.7 % vs 33.3%, P = 0.041). Conclusions Ulcerative colitis (22.2%) is not as common as reported by western countries. Small duct PSC has a better treatment response. Searching of effective treatment regimen for large bile duct PSC is warranted in future studies.
Keywords:Cholangitis,sclerosing  Colitis,ulcerative  Ursodeoxycholic acid  Cholangiopancreatography,endoscopic retrograde
本文献已被 万方数据 PubMed 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号